Tue, Mar 19, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Alternative Market Briefing

Standardization of OTC will reduce trade version, allow accurate trade models

Wednesday, August 14, 2013

Komfie Manalo, Opalesque Asia:

The upcoming standardization of OTC (over-the-counter) trades over new regulatory regimes, could drastically reduce OTC trade versions from thousands to between 10 and 20 and at the same time allow for more accurate trade models using precise data. That was the consensus amongst hedge fund managers who attended the latest Opalesque 2013 Connecticut Roundtable.

The Opalesque 2013 Connecticut Roundtable was sponsored by Eurex, Investor Analytics and Taussig Capital and took place in June 2013 in the Stamford office of Federal Street Partner.

Damian Handzy, Chief Executive of Investor Analytics, said that from a risk analyst’s perspective, a standardization of OTC trades would reduce the thousands of OTC trades to between 10 and 20 versions. "That is a much more manageable data set. And it allows you to build models, much more robust models that are far more accurate and believable from a risk perspective. The resulting transparency cuts the opportunity for mistakes and misinterpretations of the data, and it greatly improves the modeling of the securities," he said.

But for Damien Zinck, who is in charge of the Buy Side Business Development for Eurex, from an exchang......................

To view our full article Click here

Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1